Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Uridine-2',3'-vanadate is a synthetic small molecule that consists of a uridine nucleoside complexed with vanadium in the form of a vanadate ester. It belongs to the class of organic compounds known as pyrimidones and is structurally related to uridine. The compound has been studied primarily as an experimental tool in biochemical research rather than for therapeutic use. Uridine vanadates are known to act as transition-state analogs for phosphoryl transfer reactions and have been used to study enzyme mechanisms such as those involving ribonucleases. There are no approved medical indications or clinical uses for this compound; it is not marketed or approved by regulatory agencies[1][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on uridine-2',3'-vanadate.